Effect of Ticagrelor vs. Dipyridamole on Adenosine Uptake
- Registration Number
- NCT01690884
- Lead Sponsor
- Vanderbilt University
- Brief Summary
The investigators are trying to determine if a single dose of Ticagrelor will increase delivery of intraarterially-infused adenosine into the forearm interstitium, consistent with adenosine reuptake blockade.
- Detailed Description
The investigators will compare adenosine interstitial levels using a parallel design study with three groups of subjects. Forearm interstitial adenosine levels will be measured at baseline and after intrabrachial infusion of adenosine at two doses. Subjects will then randomly receive Ticagrelor 180 mg, Dipyridamole 200 mg, or placebo. Two hours later the investigators will repeat the dialysate collections at baseline and after adenosine infusions.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 28
- Subjects will be healthy volunteers, without significant pulmonary, cardiovascular gastrointestinal, hematological or renal diseases
- Not taking any regular medications
- Able to provide signed consent prior to study participation.
- History of asthma
- Pregnancy
- Exposure to an investigational drug in the last 2 months.
- Known hypersensitivity to study medications
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo Adenosine To determine if there is an increase in adenosine interstitial levels in the forearm. Dipyridamole Adenosine To determine if there is an increase in adenosine interstitial levels in the forearm. Ticagrelor Adenosine To determine if there is an increase in adenosine interstitial levels in the forearm.
- Primary Outcome Measures
Name Time Method Interstitial levels of adenosine After each dose of intrabrachial adenosine
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Autonomic Dysfunction Center
🇺🇸Nashville, Tennessee, United States